Find latest Breast videos · 500+ videos

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
M

ESMO 2024 Summary: ctDNA and Molecular Screening for Target Detection and Treatment Monitoring in mBC

By 2024 ESMO Annual Meeting Insights Hub FEATURING Michail Ignatiadis
By 2024 ESMO Annual Meeting Insights Hub FEATURING Michail Ignatiadis
172 views
September 26, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

2024 ESMO Annual Meeting Insights Hub: Breast Videos

06:23

Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Sacit…

2024 ESMO Annual Meeting Insights Hub

A. Brufsky

17 views
09:23

ESMO 2024 Insights: Adjuvant Ribociclib + NSAI in HR+/HER2- eBC - 4-…

2024 ESMO Annual Meeting Insights Hub

P. Fasching

71 views
05:07

ESMO 2024 Insights: Residual Cancer Burden & Adjuvant Capecitabine i…

2024 ESMO Annual Meeting Insights Hub

S. Kim

71 views
View All

Related Videos

Total Health

Cancer Updates GI and Breast

Thu, Feb 6, 2025
See 5 others
25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

4.4K views
06:39

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

779 views
12:14

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.3K views
06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
06:51

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

666 views
05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy
15:57

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

712 views
17:12

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.6K views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

887 views
03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh
02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
09:55

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.6K views
03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
09:12

ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, …

2024 ESMO Annual Meeting Insights Hub

V. Kaklamani

559 views
20:32

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Bre…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

560 views
29:24

ESMO 2024 Summary: Breast Cancer Highlights - AURORA Program, DAISY …

2024 ESMO Annual Meeting Insights Hub

C. Sotiriou

672 views
20:25

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

555 views
12:38

NATALEE Trial Impact on eBC: Ribociclib + ET as Adjuvant Treatment i…

Jan-Willem Henning

503 views
05:56

New

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

2024 SABCS Annual Meeting Insights Hub

A. Brufsky

299 views
48:38

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

2.6K views
AUTOPLAY